MilliporeSigma, 192185-72-1, Supplies

1 - 1 of 1
Sort
View
Show
  • MilliporeSigma

    Pre-clinical studies show that tipifarnib has antiproliferative effects on pancreatic cancer cell lines at clinically relevant concentrations (concentration that inhibits 50% growth [IC50] from 9.5 to 500 nmol/L). It also exhibits marked growth retardation and antiangiogenic effects in a…